From a fungal strain FKI-0929, two compounds designated epohelmins A and B, were isolated as new natural products with inhibitory activity against recombinant human lanosterol synthase. The crude extract from the whole broth of this strain was fractionated by silica gel column chromatography and HPLC to afford two isolated inhibitors. Detailed spectroscopic analyses led to the identification of their structures. They are diastereomers of 4,5-epoxy-2-(4'-oxoundec-(5'E)-enyl)-heptamethylenamines, and their relative stereochemical configurations were determined as (2R, 4R, 5R) or (2S, 4S, 5S) for epohelmin A, and (2R, 4S, 5R) or (2S, 4R, 5S) for epohelmin B, respectively. These compounds inhibited recombinant human lanosterol Lanosterol synthase inhibitors have a potential to reduce a risk of hypercholesterolemia. In the course of our screening project for recombinant human lanosterol synthase inhibitors, lanopylins A1, B1, A2 and B2 were isolated from Streptomyces sp. K99-5041, one of the 1,031 screened actinomycete strains1). Further screening of 280 fungal strains led us to find two new active compounds, designated epohelmins A and B (Fig. 1) , from an unidentified fungus FKI-0929. The taxonomy and fermentation of the producing strain, compound isolation, biological properties, and structure elucidation of epohelmins A and B are described in this paper. The cultured broth (3.0kg) was extracted with 50%
EtOH, concentrated and partitioned with CHCl3 twice. The organic layer was combined, dried over Na2SO4 and concentrated in vacuo to dryness to afford 2.7g of brown oily material. The crude extract was subjected to silica gel column chromatography (Wakogel(R) C-200, Wako) with a solvent system comprising CHCl3-MeOH-AcOH.
Activity was concentrated to a single spot with Rf-0. Table 1 . HR-FABMS analysis revealed that they have identical molecular formulae of C18H31O2N.
1H NMR, 13C NMR, DEPT, and HMQC spectra indicated the presence of one quaternary carbon, five methines, eleven methylenes and one methyl group in epohelmin A. Taken together with other NMR data, the structure of epohelmin A was finally determined to be 4,5-epoxy-2-(4'-oxoundec-(5'E)-enyl)-heptamethylenamine (Fig. 2) . NMR assignment of this compound is shown in Table 2 . The evidences were as follows;
1) The presence of a 4,5-epoxyheptamethylenamine moiety was identified by the following NMR data: the 1H-and 2.96), and the 1H-13C long-range couplings from H-2 to 5, C-6 and C-8, and from H-8 to C-2. C-6 and C-7. The NMR data of this moiety in known synthetic compounds2,3) support this structure. To the best of our knowledge, this is the first report of the isolation of natural products with this moiety.
2) Attachment of the 4'-oxoundec-(5'E)-enyl side chain at the position 2 was indicated by the following facts:
3' to C-1', C-2' and C-4', from H-5' to C-3', C-4' and C-7' H-9' to C-10', from H-10' to C-9', and from H-11' to C-9' and C-10'. This is also supported by the observation of the signals at m/z 293 ([M]+) and 126 (base peak) in the EIMS spectrum (Table 1) .
3) The relative stereochemical configuration of the 4,5-epoxyheptamethylenamine backbone was elucidated to be (2R, 4R, 5R) or (2S, 4S, 5S) by the coupling constant between H-4 and H-5 (3JH-H=3.0Hz) and the NOEs among H-3, H-5 and H-7, and among H-4, H-6, H-8 and H-1' as presented in Fig. 3 . In the same manner, the planer structure of epohelmin B was finally elucidated to be identical to that of epohelmin A. NMR assignment of epohelmin B is also presented in Understanding the biosynthesis of epohelmins will be important because this is the first isolation of the natural product with 4,5-epoxyheptamethylenamine structure.
Hypothetical pathways can be derived from fundamental principals of biosynthesis (Fig. 4) . The heptamethylen 
